Cinaciguat
| CAS No. | 329773-35-5 | Cat. No. | BCP07942 |
| Name | Cinaciguat | ||
| Synonyms | BAY582667; BAY 58-2667; | ||
| Formula | C36H39NO5 | M. Wt | 565.7 |
| Description | Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure. Cinaciguat has potent preload- and afterload-reducing effects, increasing cardiac output. Cinaciguat causes potent and sustained fetal pulmonary vasodilation that is augmented in the presence of oxidized sGC and speculate that Cinaciguat may have therapeutic potential for severe neonatal pulmonary hypertension. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Guanylate Cyclase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.